AU5996294A - Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and DNA sequences of the same - Google Patents

Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and DNA sequences of the same

Info

Publication number
AU5996294A
AU5996294A AU59962/94A AU5996294A AU5996294A AU 5996294 A AU5996294 A AU 5996294A AU 59962/94 A AU59962/94 A AU 59962/94A AU 5996294 A AU5996294 A AU 5996294A AU 5996294 A AU5996294 A AU 5996294A
Authority
AU
Australia
Prior art keywords
gly
ser
glu
fasciola
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59962/94A
Other languages
English (en)
Inventor
Andrew Richard Milner
Michel Panaccio
Terence William Spithill
Gene Louise Wijffels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agriculture Victoria Services Pty Ltd
Original Assignee
Daratech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daratech Pty Ltd filed Critical Daratech Pty Ltd
Priority to AU59962/94A priority Critical patent/AU5996294A/en
Publication of AU5996294A publication Critical patent/AU5996294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU59962/94A 1993-02-05 1994-02-04 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and DNA sequences of the same Abandoned AU5996294A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU59962/94A AU5996294A (en) 1993-02-05 1994-02-04 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and DNA sequences of the same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPL710993 1993-02-05
AUPL7109 1993-02-05
AU59962/94A AU5996294A (en) 1993-02-05 1994-02-04 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and DNA sequences of the same
PCT/AU1994/000051 WO1994017820A1 (en) 1993-02-05 1994-02-04 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same

Publications (1)

Publication Number Publication Date
AU5996294A true AU5996294A (en) 1994-08-29

Family

ID=3776688

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59962/94A Abandoned AU5996294A (en) 1993-02-05 1994-02-04 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and DNA sequences of the same

Country Status (8)

Country Link
EP (1) EP0647138A4 (enExample)
JP (1) JPH07505787A (enExample)
AU (1) AU5996294A (enExample)
BR (1) BR9404004A (enExample)
CA (1) CA2126455A1 (enExample)
NO (1) NO942360L (enExample)
NZ (1) NZ261279A (enExample)
WO (1) WO1994017820A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09502988A (ja) * 1993-09-28 1997-03-25 ザ・ユニバーシテイ・オブ・メルボルン 寄生虫に対する感染防御抗原
US6551594B1 (en) 1997-03-11 2003-04-22 Stichting Dienst Landbouwkundig Onderzoek Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
WO2002038744A2 (en) * 2000-10-18 2002-05-16 Incyte Genomics, Inc. Proteases
PT1543038T (pt) 2002-09-11 2017-07-07 Genentech Inc Purificação de proteína
PL201419B1 (pl) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina
PL196114B1 (pl) * 2002-12-31 2007-12-31 Inst Biotechnologii I Antybiot Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt
MX2012004133A (es) * 2009-10-07 2012-05-08 Wyeth Llc Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas.
ES2525106B1 (es) * 2013-06-17 2015-09-29 Universidad De Salamanca Péptido sintético derivado de Fasciola hepatica y su uso como vacuna
GB201714057D0 (en) * 2017-09-01 2017-10-18 Univ College Dublin Nat Univ Of Ireland Dublin A fasciola hepatica antigen and vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
AU7871987A (en) * 1986-08-18 1988-03-08 Australian National University, The Helminth parasite vaccine
BR9007070A (pt) * 1989-01-31 1991-11-12 Daratech Pty Ltd Vacina para o tratamento preventivo de infeccao por vermes trematoides do figado em ruminantes
JP2700088B2 (ja) * 1991-07-25 1998-01-19 房則 濱島 免疫抑制剤
ES2199947T3 (es) * 1992-10-21 2004-03-01 John Pius Dalton Vacuna que contiene una tiolproteasa.

Also Published As

Publication number Publication date
CA2126455A1 (en) 1994-08-06
NO942360L (no) 1994-10-05
NO942360D0 (enExample) 1994-06-21
BR9404004A (pt) 1999-05-25
WO1994017820A1 (en) 1994-08-18
EP0647138A4 (en) 1996-03-06
EP0647138A1 (en) 1995-04-12
NZ261279A (en) 1996-03-26
JPH07505787A (ja) 1995-06-29

Similar Documents

Publication Publication Date Title
Cho et al. Cathepsin D produces antimicrobial peptide parasin I from histone H2A in the skin mucosa of fish
Redmond et al. Protection studies in sheep using affinity-purified and recombinant cysteine proteinases of adult Haemonchus contortus
WO1994017820A1 (en) Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same
AU675214B2 (en) Protease vaccine against heartworm
AU705715B2 (en) Use of flea proteases and protease inhibitors to protect animals from flea infestation
EP0524834A2 (en) Immunosuppressive drugs containing a cysteine protease
US6623735B1 (en) Vaccine containing a thiol protease
US6180383B1 (en) Flea leucine aminopeptidase proteins and uses thereof
US6413521B1 (en) Helminth parasite antigen with aminopeptidase-like activity
US20080286817A1 (en) Novel allergens and treatment
AU2651695A (en) Novel parasite protease genes and proteins
TOSA et al. Puritication and Identification of a Serum Protein Increased by Anthelmintic Drugs for Dirofilaria immitis in Dogs
AU2005280742B2 (en) Immunogen and antivenom against violin spider venom
CA2252581A1 (en) Flea protease proteins, nucleic acid molecules, and uses thereof
EP0362274A1 (en) TREATMENT AND DIAGNOSIS OF CLAUS DISEASE USING THE BASIC PROTEASE OF BACTEROIDES NODOSUS.
AU2013217398A1 (en) Sheep nematode vaccine
AU701642B2 (en) Vaccines against helminthic parasites
US6406900B1 (en) Flea protease proteins, nucleic acid molecules and uses thereof
WO1995012679A1 (en) Anti-helminth vaccines
AU2001252799A1 (en) Sheep lice, Bovicola Ovis, Allergen Treatment
US6214579B1 (en) Flea leucine aminopeptidase nucleic acid molecules and uses thereof
AU731026B2 (en) Vaccine containing a thiol protease
MX2007002425A (en) Immunogen and antivenom against violin spider venom